DCF — FREESTONE MEDICAL CENTER
Enterprise Value: $-35.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-35.5M
Enterprise Value
$-11.0M
PV of Cash Flows
$-24.5M
PV of Terminal Value
$-39.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $14.7M | $-2.3M | -16.0% | $-3.0M | $-2.7M |
| Year 2 | $15.1M | $-2.3M | -15.0% | $-2.9M | $-2.4M |
| Year 3 | $15.6M | $-2.2M | -14.0% | $-2.8M | $-2.1M |
| Year 4 | $16.0M | $-2.2M | -13.0% | $-2.8M | $-1.9M |
| Year 5 | $16.5M | $-2.2M | -13.0% | $-2.9M | $-1.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-35.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$14.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.16497152427493972
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5